Bionano Genomics Stock Options

BNGO Stock  USD 1.89  0.15  8.62%   

Bionano Genomics Market Cap Over Time

   Market Cap   
       Timeline  

Bionano Total Stockholder Equity

Total Stockholder Equity

33.61 Million

At this time, Bionano Genomics' Total Stockholder Equity is very stable compared to the past year.

Bionano Genomics Corporate Management

Jonathan JDGeneral SecretaryProfile
Donna PolizioGlobal AccessProfile
Klint RoseHead DevelopmentProfile
Helene KleinChief OfficerProfile
Sheila MBAVice MarketingProfile
Christopher StewartChief OfficerProfile
Jonathan DixonGlobal LegalProfile
When determining whether Bionano Genomics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bionano Genomics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bionano Genomics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bionano Genomics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bionano Genomics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
To learn how to invest in Bionano Stock, please use our How to Invest in Bionano Genomics guide.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bionano Genomics. If investors know Bionano will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bionano Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(45.98)
Revenue Per Share
11.901
Quarterly Revenue Growth
(0.13)
Return On Assets
(0.31)
Return On Equity
(1.18)
The market value of Bionano Genomics is measured differently than its book value, which is the value of Bionano that is recorded on the company's balance sheet. Investors also form their own opinion of Bionano Genomics' value that differs from its market value or its book value, called intrinsic value, which is Bionano Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bionano Genomics' market value can be influenced by many factors that don't directly affect Bionano Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bionano Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bionano Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bionano Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.